P-com Pharmaceutical & Biotechnology http://www.philly.com/philly/jobs/industries/pharma RSS Feed for P-com Jobs Pharmaceutical & Biotechnology en-us Tue, 16 Jun 2009 19:00:46 GMT Vitae Pharmaceuticals links up with Boehringer Ingelheim for 2nd R&D area http://www.philly.com/philly/jobs/industries/pharma/Vitae_Pharmaceuticals_links_up_with_Boehringer_Ingelheim_for_2nd_RD_area.html The small Fort Washington drug developer will receive $42 million up front from the large German pharmaceutical maker. Wyeth accused of overcharging for drug http://www.philly.com/philly/jobs/industries/pharma/20090519_Wyeth_accused_on_price_of_drug.html WASHINGTON - The Justice Department yesterday accused Wyeth, one of the nation's biggest drugmakers, of cheating Medicaid programs out of hundreds of millions of dollars by overcharging for a stomach-acid drug. Phila. near top in life-sciences industry: Study http://www.philly.com/philly/jobs/industries/pharma/20090519_Phila__posts_near_top_in_life-sciences_industry__Study.html The Philadelphia area ranks behind only Boston in terms of the vibrancy of its life-sciences industry, according to a new national study. Medical advances will alter the FDA http://www.philly.com/philly/jobs/industries/pharma/20081108_Medical_advances_will_alter_the_FDA.html Revolutionary medical advances will force dramatic changes in the ways that drugs are tested and approved and will require pharmaceutical companies to overhaul their businesses, the outgoing head of the U.S. Food and Drug Administration said yesterday. Gardasil for males? Report hikes hopes http://www.philly.com/philly/jobs/industries/pharma/20081114_Gardasil_for_males__Report_hikes_hopes.html Will yesterday's news that Merck's Gardasil vaccine may protect men, as well as women, from a deadly virus bolster sales of a product that so far has failed to fulfill its maker's hopes for a blockbuster? Doctors: Vytorin-cancer link can’t be ruled out http://www.philly.com/philly/jobs/industries/pharma/20080902_Doctors__Vytorin-cancer_link_cant_be_ruled_out.html MUNICH, Germany - Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday. Wistar lab cracks a cancer mystery http://www.philly.com/philly/jobs/industries/pharma/20080901_Wistar_lab_cracks_a_cancer_mystery.html Emmanuel Skordalakes scrutinized the genetic makeup of pigs and cows and rats and hundreds of other creatures before the red flour beetle, an eighth-of-an-inch-long pest found in Southern kitchens, delivered the breakthrough scientists had sought for more than a decade. PACKING POWER INTO PRODUCTS http://www.philly.com/philly/jobs/industries/pharma/20080810_PACKING_POWER_INTO_PRODUCTS.html The letter P, to some ears, stands for power. So it's no coincidence that a plethora of drugs - from Prozac to Provenge - feature this brawny consonant. Covance buys Eli Lilly facility in 10-year deal http://www.philly.com/philly/jobs/industries/pharma/20080807_Covance_buys_Eli_Lilly_facility_in_10-year_deal.html INDIANAPOLIS - Drug-development services company Covance Inc. will buy an Indiana research center from Eli Lilly and Co. and enter a 10-year service deal with the drugmaker worth $1.6 billion. DEA clears Lannett for pain-med ingredients http://www.philly.com/philly/jobs/industries/pharma/20080728_DEA_clears_Lannett_for_pain-med_ingredients.html PHILADELPHIA - Lannett Company Inc., a manufacturer of generic pharmaceuticals, said that its wholly owned subsidiary, Cody Laboratories, has received approval from the U.S. Drug Enforcement Administration to directly import raw materials for processing into controlled substance medication for pain management.